Haibu Pharmaceutical has <↑§been awarded the "Top 50 Pharmaceπφγutical R&D Comγ® panies in China" for c→∏♦onsecutive years.
Classification:
Company News
Release time:
2023-09-18
On July 4, 2023, the "2022-20¥π<23 Annual Release Conferenc₽£e of the Most Influen↕♠tial List in China's Phar←$₽®maceutical Industry · The 15th China →™ Pharmaceutical Industπ¶ ry Development Summit Forum" was gran∏§dly held in Harbin, co-hoste×>βd by the National Federation of Industr♦₹y and Commerce Pharmα₽€✘aceutical Industry Chamber γ×of Commerce, Heilongjiang ProvincialΩ ™ Federation of Industry and Commer∞✔ce, and Heilongjiang P rovincial DevelopmentΩ ¶ and Reform Commission. The conferλ∞ence focused on "Promoti$₹ng High-Quality Development o★©f the Industry and Revλ↔∑italizing Northeast Medi$←cine," interpreting policie✔s and discussing hot topics in the p←→÷↑harmaceutical industry f<&★rom different perspectives. Undeπ¥r the background of the "Healthy← China" strategy, it∑$ addressed the opportu<σnities and challenges faced by the pharδ∑maceutical industry.
The China Pharmaceutical Industry Devel→λopment Summit Forum is one of the hig↑↕ ©hest-level and most influeδ♣"≤ntial industry events. It aims to guide$→↓ entrepreneurs in the pharmaceutic≠al industry to operate ₩♠☆honestly and legally, using th ↑Ωe chamber of commerce aβ©♣s a hub to gather advantageous♦ ∞£ resources for high-qualit$♥®×y development in the pharmaceutical indγ∞ustry, promote deep integrati₽π<on of industrial chains, ¶σadvance technological inno$ €vation among member enterpri ↔ses, and foster speciaγ★γlized and innovative d↓©♣σevelopment. This will ✘ continuously enhance innovative t$hinking and developmental thinking, pr∏σomoting high-quality developφ&ment for enterprises as a whole.
Haibu Pharmaceutical has been awarded "φ Top 50 Chinese Pharmaceutical R&Dσ∏δ Companies" for consecuti₹ ¥ve years.



